S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:PTE

PolarityTE Stock Competitors

$2.35
-0.51 (-17.83%)
(As of 05/20/2022 04:00 PM ET)
Add
Compare
Today's Range
$2.32
$2.95
50-Day Range
$2.35
$74.25
52-Week Range
$2.32
$29.50
Volume
265,605 shs
Average Volume
316,428 shs
Market Capitalization
$9.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.13

PolarityTE (NASDAQ:PTE) Vs. AGTC, INKT, EVAX, INAB, ERYP, XFOR, TCON, AVRO, TARA, and MBOT

Should you be buying PolarityTE stock or one of its competitors? The main competitors of PolarityTE include Applied Genetic Technologies (AGTC), MiNK Therapeutics (INKT), Evaxion Biotech A/S (EVAX), IN8bio (INAB), ERYTECH Pharma (ERYP), X4 Pharmaceuticals (XFOR), TRACON Pharmaceuticals (TCON), AVROBIO (AVRO), Protara Therapeutics (TARA), and Microbot Medical (MBOT). These companies are all part of the "biological products, except diagnostic" industry.

PolarityTE vs.

PolarityTE (NASDAQ:PTE) and Applied Genetic Technologies (NASDAQ:AGTC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, community ranking, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

In the previous week, PolarityTE had 3 more articles in the media than Applied Genetic Technologies. MarketBeat recorded 16 mentions for PolarityTE and 13 mentions for Applied Genetic Technologies. Applied Genetic Technologies' average media sentiment score of 0.88 beat PolarityTE's score of 0.18 indicating that Applied Genetic Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PolarityTE
2 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Applied Genetic Technologies
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PolarityTE has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Applied Genetic Technologies has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500.

11.1% of PolarityTE shares are held by institutional investors. Comparatively, 38.0% of Applied Genetic Technologies shares are held by institutional investors. 5.4% of PolarityTE shares are held by insiders. Comparatively, 4.1% of Applied Genetic Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Applied Genetic Technologies has a net margin of 0.00% compared to PolarityTE's net margin of -304.42%. Applied Genetic Technologies' return on equity of -98.79% beat PolarityTE's return on equity.

Company Net Margins Return on Equity Return on Assets
PolarityTE -304.42% -132.71% -79.78%
Applied Genetic Technologies N/A -98.79% -60.15%

PolarityTE has higher revenue and earnings than Applied Genetic Technologies. Applied Genetic Technologies is trading at a lower price-to-earnings ratio than PolarityTE, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PolarityTE$9.40 million1.00-$30.19 million-$6.25-0.38
Applied Genetic Technologies$500 thousand89.55-$57.83 million-$1.46-0.60

Applied Genetic Technologies has a consensus target price of $15.00, suggesting a potential upside of 1,599.52%. Given Applied Genetic Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Applied Genetic Technologies is more favorable than PolarityTE.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PolarityTE
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Applied Genetic Technologies
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

Applied Genetic Technologies received 296 more outperform votes than PolarityTE when rated by MarketBeat users. Likewise, 75.48% of users gave Applied Genetic Technologies an outperform vote while only 69.23% of users gave PolarityTE an outperform vote.

CompanyUnderperformOutperform
PolarityTEOutperform Votes
135
69.23%
Underperform Votes
60
30.77%
Applied Genetic TechnologiesOutperform Votes
431
75.48%
Underperform Votes
140
24.52%

Summary

Applied Genetic Technologies beats PolarityTE on 13 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PolarityTE (NASDAQ:PTE) vs. Its Competitors

MetricPolarityTEBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$11.44M$2.61B$4.32B$5.71B
Dividend YieldN/A2.26%2.02%3.19%
P/E Ratio-0.383.059.0711.22
Price / Sales1.00217.502,413.07102.30
Price / CashN/A16.5622.9283.75
Price / Book0.534.074.034.63
Net Income-$30.19M$102.32M$164.30M$240.07M
7 Day Performance-55.66%1.25%1.10%0.26%
1 Month Performance-54.37%-15.90%-14.06%-11.22%
1 Year Performance-91.68%-41.80%-31.00%-26.98%

PolarityTE Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGTC
Applied Genetic Technologies
1.95 of 5 stars
$0.88
-3.3%
$15.00
+1,599.5%
-79.5%$44.77M$500K-0.6083Analyst Report
Analyst Revision
News Coverage
High Trading Volume
INKT
MiNK Therapeutics
1.3665 of 5 stars
$1.31
+0.8%
$21.00
+1,503.1%
N/A$43.96M$690K0.0033Gap Up
EVAX
Evaxion Biotech A/S
1.4198 of 5 stars
$1.86
+1.6%
$22.00
+1,082.8%
-74.4%$43.15MN/A-1.4661
INAB
IN8bio
1.5448 of 5 stars
$2.19
-15.1%
$10.50
+379.5%
N/A$41.26MN/A-1.2219Analyst Revision
News Coverage
Gap Down
High Trading Volume
ERYP
ERYTECH Pharma
0.8981 of 5 stars
$1.18
+2.6%
N/A-81.2%$36.60M$4.95M0.00196Gap Down
XFOR
X4 Pharmaceuticals
2.1631 of 5 stars
$1.16
-4.9%
$12.08
+941.7%
-84.4%$35.75M$3M-0.3483Analyst Report
Short Interest ↓
TCON
TRACON Pharmaceuticals
2.4664 of 5 stars
$1.77
-4.8%
$11.50
+549.7%
-70.5%$35.54M$350K-0.9619Analyst Report
AVRO
AVROBIO
2.1564 of 5 stars
$0.79
+2.6%
$7.50
+848.2%
-91.2%$34.57MN/A-0.28122Gap Up
TARA
Protara Therapeutics
2.5831 of 5 stars
$3.07
-1.3%
$37.00
+1,105.2%
-67.3%$34.54MN/A-0.7731Analyst Downgrade
MBOT
Microbot Medical
1.0998 of 5 stars
$4.85
-3.4%
N/A-32.2%$34.48MN/A-3.4214Upcoming Earnings
Analyst Upgrade
News Coverage
Gap Up
RCOR
Renovacor
2.1583 of 5 stars
$1.96
-1.5%
$21.00
+971.4%
N/A$33.85MN/A0.0019Analyst Downgrade
News Coverage
CDTX
Cidara Therapeutics
2.1114 of 5 stars
$0.44
-6.3%
$6.45
+1,352.7%
-78.6%$32.79M$49.57M-0.6289Analyst Downgrade
Gap Up
AYLA
Ayala Pharmaceuticals
1.7115 of 5 stars
$2.10
-4.5%
$18.14
+763.9%
-79.1%$30.99M$3.51M-0.7635Analyst Revision
News Coverage
ELOX
Eloxx Pharmaceuticals
1.6215 of 5 stars
$0.34
-2.9%
$3.02
+798.8%
-78.9%$30.25MN/A-0.3725News Coverage
Gap Down
BCDA
BioCardia
2.1048 of 5 stars
$1.63
+3.2%
$9.00
+452.1%
-57.9%$27.57M$1.01M-2.1428Gap Up
IDRA
Idera Pharmaceuticals
0.9331 of 5 stars
$0.52
+8.3%
N/A-52.7%$27.55M$1.45M-1.2432Analyst Report
FRLN
Freeline Therapeutics
2.0792 of 5 stars
$0.74
-2.6%
$12.00
+1,530.4%
-91.8%$26.44MN/A-0.21236News Coverage
Gap Down
ONVO
Organovo
0.9781 of 5 stars
$2.47
-11.5%
N/A-66.6%$24.29M$2.20M-1.7812Analyst Report
Gap Down
GENE
Genetic Technologies
0.7465 of 5 stars
$1.31
flat
N/A-66.2%$20.16M$90K0.0018News Coverage
Positive News
BBI
Brickell Biotech
1.3515 of 5 stars
$0.16
-5.8%
$2.00
+1,127.0%
-82.1%$20.07M$400K-0.3516Analyst Downgrade
News Coverage
WINT
Windtree Therapeutics
2.45 of 5 stars
$0.57
+5.6%
$8.00
+1,306.0%
-66.3%$16.73M$200K-0.2331Gap Up
IKT
Inhibikase Therapeutics
2.1583 of 5 stars
$0.66
+4.8%
$12.00
+1,729.3%
-86.2%$15.89M$3.10M-0.843Earnings Report
News Coverage
Gap Up
High Trading Volume
BVXV
BiondVax Pharmaceuticals
1.5531 of 5 stars
$1.30
+0.8%
$7.00
+438.5%
-55.6%$14.65MN/A-1.7115Analyst Report
News Coverage
LOGC
LogicBio Therapeutics
2.1581 of 5 stars
$0.44
+2.3%
$11.25
+2,472.0%
-90.1%$14.42M$5.41M-0.3962Earnings Report
Analyst Revision
ALNA
Allena Pharmaceuticals
1.7714 of 5 stars
$0.12
-7.8%
$3.00
+2,442.4%
-90.1%$13.36MN/A-0.1435Earnings Report
Upcoming Earnings
Positive News
GNCA
Genocea Biosciences
1.9914 of 5 stars
$0.21
-4.6%
$3.00
+1,336.1%
-91.0%$12.27M$1.64M-0.3474Upcoming Earnings
Analyst Report
Gap Up
PALI
Palisade Bio
1.8116 of 5 stars
$0.52
+2.0%
$6.00
+1,053.8%
-86.1%$11.27M$10K-0.1613Earnings Report
Analyst Upgrade
News Coverage
Gap Up
CRXT
Clarus Therapeutics
1.825 of 5 stars
$0.39
-4.9%
$10.20
+2,502.0%
N/A$9.70M$13.96M0.002Analyst Report
Analyst Revision
ACOR
Acorda Therapeutics
1.7915 of 5 stars
$0.52
-7.2%
$10.00
+1,841.7%
-87.5%$6.84M$129.07M-0.06118Analyst Report
Gap Up
High Trading Volume
CYTR
CytRx
0.1667 of 5 stars
$0.14
+7.5%
N/AN/A$6.25MN/A0.003Analyst Report
News Coverage
KRBP
Kiromic BioPharma
1.4583 of 5 stars
$0.31
-8.9%
N/A-95.2%$5.17MN/A-0.3819Analyst Revision
TTNP
Titan Pharmaceuticals
1.0314 of 5 stars
$0.39
+2.6%
N/A-83.4%$4.73M$1.53M0.0011Upcoming Earnings
Analyst Report
News Coverage
Gap Up
TCBP
TC Biopharm
0 of 5 stars
$1.12
-2.6%
N/AN/A$4.21MN/A0.0074Gap Up
CGEN
Compugen
1.6064 of 5 stars
$1.87
-3.6%
$13.67
+630.8%
-77.3%$0.00$6M-4.7973Earnings Report
Analyst Revision
News Coverage
Gap Up
This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.